Associating SARS-CoV-2 Serological Assays with Protection: Where the Field Stands.
作者信息
Tang Mei San, Farnsworth Christopher W
机构信息
Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO.
出版信息
Clin Chem. 2021 Apr 29;67(5):707-709. doi: 10.1093/clinchem/hvab039.
Abstract
摘要
相似文献
1
Associating SARS-CoV-2 Serological Assays with Protection: Where the Field Stands.将严重急性呼吸综合征冠状病毒2血清学检测与保护作用相关联：该领域现状
Clin Chem. 2021 Apr 29;67(5):707-709. doi: 10.1093/clinchem/hvab039.
2
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.血清学检测评估康复的新冠肺炎患者中高度可变的新冠病毒中和抗体活性。
J Clin Microbiol. 2020 Nov 18;58(12). doi: 10.1128/JCM.02005-20.
3
Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects.康复的 COVID-19 患者体内抗 SARS-CoV-2 抗体的特征。
Viruses. 2021 Apr 16;13(4):697. doi: 10.3390/v13040697.
4
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays.新型冠状病毒中和抗体与商业血清学检测的相关性。
Clin Chem. 2020 Dec 1;66(12):1538-1547. doi: 10.1093/clinchem/hvaa211.
5
A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology Assays.跨国政府合作独立评估 SARS-CoV-2 血清学检测方法
Microbiol Spectr. 2022 Feb 23;10(1):e0156421. doi: 10.1128/spectrum.01564-21. Epub 2022 Jan 12.
6
Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.远程末梢血采集用于严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）抗体检测。
Arch Pathol Lab Med. 2021 Apr 1;145(4):415-418. doi: 10.5858/arpa.2020-0713-SA.
7
Humoral Responses and Serological Assays in SARS-CoV-2 Infections.体液免疫反应和血清学检测在严重急性呼吸综合征冠状病毒 2 感染中的作用。
Front Immunol. 2020 Dec 18;11:610688. doi: 10.3389/fimmu.2020.610688. eCollection 2020.
8
Application, Verification, and Implementation of SARS-CoV-2 Serologic Assays with Emergency Use Authorization.紧急使用授权下的 SARS-CoV-2 血清学检测的应用、验证和实施。
J Clin Microbiol. 2020 Dec 17;59(1). doi: 10.1128/JCM.02148-20.
9
B careful: Humoral responses and COVID-19 severity.注意：体液免疫应答与 COVID-19 严重程度。
Sci Immunol. 2020 Dec 4;5(54). doi: 10.1126/sciimmunol.abf8870.
10
Correlation of SARS-CoV-2 Neutralizing Antibodies to an Automated Chemiluminescent Serological Immunoassay.SARS-CoV-2 中和抗体与自动化化学发光血清免疫分析的相关性。
J Appl Lab Med. 2021 Mar 1;6(2):491-495. doi: 10.1093/jalm/jfaa195.
引用本文的文献
1
Head-to-Head Comparison of 5 Anti-SARS-CoV-2 Assays Performance in One Hundred COVID-19 Vaccinees, over an 8-Month Course.在100名COVID-19疫苗接种者中，对5种抗SARS-CoV-2检测方法的性能进行为期8个月的直接比较。
Diagnostics (Basel). 2022 Jun 9;12(6):1426. doi: 10.3390/diagnostics12061426.
2
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects.使用接种疫苗人群的血清对六种定量 SARS-CoV-2 血清学检测方法进行协调。
Clin Chim Acta. 2021 Nov;522:144-151. doi: 10.1016/j.cca.2021.08.024. Epub 2021 Aug 20.
3
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2.辉瑞-BioNTech 两剂疫苗接种后 COVID-19 患者和疫苗接种者的中和抗体。
Viruses. 2021 Jul 14;13(7):1364. doi: 10.3390/v13071364.
本文引用的文献
1
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.在 COVID-19 和恢复期，针对 SARS-CoV-2 刺突和核衣壳蛋白快速产生持久的 B 细胞记忆。
Sci Immunol. 2020 Dec 22;5(54). doi: 10.1126/sciimmunol.abf8891.
2
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test.高通量 SARS-CoV-2 血清学检测在轻症 COVID-19 患者纵向队列中的评估：临床敏感性、特异性和与病毒中和试验的关联。
Clin Chem. 2021 Apr 29;67(5):742-752. doi: 10.1093/clinchem/hvaa336.
3
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.医护人员中抗SARS-CoV-2抗体状态及感染发生率
N Engl J Med. 2021 Feb 11;384(6):533-540. doi: 10.1056/NEJMoa2034545. Epub 2020 Dec 23.
4
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.无症状和轻症 SARS-CoV-2 感染患者中和抗体和 T 细胞反应的不一致性。
Sci Immunol. 2020 Dec 23;5(54). doi: 10.1126/sciimmunol.abf3698.
5
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays.新型冠状病毒中和抗体与商业血清学检测的相关性。
Clin Chem. 2020 Dec 1;66(12):1538-1547. doi: 10.1093/clinchem/hvaa211.
6
Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate.中和抗体与高感染率渔业船舶暴发期间人类免受 SARS-CoV-2 感染相关。
J Clin Microbiol. 2020 Oct 21;58(11). doi: 10.1128/JCM.02107-20.
7
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.性别、年龄和住院情况会影响 COVID-19 恢复期血浆捐献者人群的抗体反应。
J Clin Invest. 2020 Nov 2;130(11):6141-6150. doi: 10.1172/JCI142004.
8
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.轻度新冠肺炎患者体内抗SARS-CoV-2抗体的快速衰减
N Engl J Med. 2020 Sep 10;383(11):1085-1087. doi: 10.1056/NEJMc2025179. Epub 2020 Jul 21.
9
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.mRNA 疫苗对 SARS-CoV-2 的作用-初步报告。
N Engl J Med. 2020 Nov 12;383(20):1920-1931. doi: 10.1056/NEJMoa2022483. Epub 2020 Jul 14.
10
Waiting for Certainty on Covid-19 Antibody Tests - At What Cost?等待新冠病毒抗体检测结果确定——代价几何？
N Engl J Med. 2020 Aug 6;383(6):e37. doi: 10.1056/NEJMp2017739. Epub 2020 Jun 5.
Zotero 插件